MANCHESTER, UNITED KINGDOM, March 10, 2026 /EINPresswire.com/ -- Monument Therapeutics, a stratified medicine company, ...

SHINKEI THERAPEUTICS RECEIVES FDA CLEARANCE TO PROCEED WITH PHASE 1 CLINICAL TRIAL FOR MR-101 AND COMPLETES PHASE 2 ...

Eye experts at Flinders University have released new global findings that reveal how a rare eye cancer first appears, offering vital insights that will help doctors diagnose the disease earlier and ...

The Wall Street giant secured the sell-side mandate after Blackstone’s private equity team interviewed a handful of ...

The University of Warwick, which is setting up the Registry, plans to collect data for analysis from 500 AML patients at sites in 30 large metropolitan NHS hospitals across the UK by the end of this ...

In the UK, wide‑ranging reforms coming into force on 28 April 2026 are designed to streamline approvals, embed a more ...

A new clinical research centre, which also aims to improve access to preventative healthcare, has opened in Sunderland city centre.

14 CHU de Strasbourg, Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France 15 Sorbonne Universités, UPMC Paris 06, Brain and Spine Institute, ICM, ...

Worldwide Clinical Trials is expanding its horizons with the acquisition of Catalyst Clinical Research, a specialist oncology organization with a particular knack for early-stage cancer trials. The ...

Dry eye disease (DED), also known as keratoconjunctivitis sicca (KCS), imposes a substantial global burden, yet the clinical trial landscape guiding therapeutic development remains incompletely ...

OKAVA Pharmaceuticals, a San Francisco-based biopharmaceutical company, has started a first-of-its-kind clinical trial evaluating a weight loss therapy for obese cats using a GLP-1 implant, the ...

A study found that NIH grant cuts under the Trump administration in 2025 have already led to the termination of 118 trials studying cancer, 97 studying infectious diseases and 140 testing new ...